EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Bilateral active chorioretinal lesions and fundus hemorrhage in a 23-month-old male with CYBB mutation: a case report

Fangfang Li, Hua Lv, Yuci Zhang, Jing Yin, Chongwei Li

Translational Pediatrics · 2026-06 · 15 (6) · 257-257

DOI: 10.21037/tp-2026-1-0080 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Translational Pediatrics, 2026-06. Verfasst von Fangfang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Children's Hospital, Tianjin University/Tianjin Children's Hospital, Tianjin, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CYBBChronic granulomatous disease (CGD)case reportchorioretinal lesionsfundus hemorrhage

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Children's Hospital, Tianjin University/Tianjin Children's Hospital, Tianjin, China.
  • Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, China.

Zitieren

APA

Li, F., Lv, H., Zhang, Y., Yin, J., & Li, C. (2026). Bilateral active chorioretinal lesions and fundus hemorrhage in a 23-month-old male with CYBB mutation: a case report. Translational Pediatrics, 15(6), 257-257. https://doi.org/10.21037/tp-2026-1-0080

Vancouver

Li F, Lv H, Zhang Y, Yin J, Li C. Bilateral active chorioretinal lesions and fundus hemorrhage in a 23-month-old male with CYBB mutation: a case report. Translational Pediatrics. 2026;15(6):257-257. doi:10.21037/tp-2026-1-0080

BibTeX
@article{Li2026,
  author = {Li, Fangfang and Lv, Hua and Zhang, Yuci and Yin, Jing and Li, Chongwei},
  title = {Bilateral active chorioretinal lesions and fundus hemorrhage in a 23-month-old male with CYBB mutation: a case report},
  journal = {Translational Pediatrics},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {257--257},
  doi = {10.21037/tp-2026-1-0080}
}
Kostenlos starten →